131 related articles for article (PubMed ID: 9680178)
1. Plasma proteins in acute and chronic lung disease of the newborn.
Moison RM; Haasnoot AA; Van Zoeren-Grobben D; Berger HM
Free Radic Biol Med; 1998 Aug; 25(3):321-8. PubMed ID: 9680178
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell glutathione and plasma sulfhydryls in chronic lung disease of the newborn.
Moison RM; Haasnoot AA; van Zoeren-Grobben D; Berger HM
Acta Paediatr; 1997 Dec; 86(12):1363-9. PubMed ID: 9475317
[TBL] [Abstract][Full Text] [Related]
3. Uric acid and ascorbic acid redox ratios in plasma and tracheal aspirate of preterm babies with acute and chronic lung disease.
Moison RM; de Beaufort AJ; Haasnoot AA; Dubbelman TM; van Zoeren-Grobben D; Berger HM
Free Radic Biol Med; 1997; 23(2):226-34. PubMed ID: 9199884
[TBL] [Abstract][Full Text] [Related]
4. Postnatal changes in plasma ceruloplasmin and transferrin antioxidant activities in preterm babies.
Lindeman JH; Lentjes EG; van Zoeren-Grobben D; Berger HM
Biol Neonate; 2000; 78(2):73-6. PubMed ID: 10970997
[TBL] [Abstract][Full Text] [Related]
5. Blood transfusion and chronic lung disease in preterm infants.
Cooke RW; Drury JA; Yoxall CW; James C
Eur J Pediatr; 1997 Jan; 156(1):47-50. PubMed ID: 9007491
[TBL] [Abstract][Full Text] [Related]
6. Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies.
Moison RM; Palinckx JJ; Roest M; Houdkamp E; Berger HM
Lancet; 1993 Jan; 341(8837):79-82. PubMed ID: 8093405
[TBL] [Abstract][Full Text] [Related]
7. Diminished protection against copper-induced lipid peroxidation by cord blood plasma of preterm and term infants.
Lindeman JH; Lentjes EG; Berger HM
JPEN J Parenter Enteral Nutr; 1995; 19(5):373-5. PubMed ID: 8577014
[TBL] [Abstract][Full Text] [Related]
8. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.
Falciglia HS; Johnson JR; Sullivan J; Hall CF; Miller JD; Riechmann GC; Falciglia GA
Am J Perinatol; 2003 Feb; 20(2):97-107. PubMed ID: 12660915
[TBL] [Abstract][Full Text] [Related]
9. Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease.
Ogihara T; Hirano K; Morinobu T; Kim HS; Hiroi M; Ogihara H; Tamai H
Arch Dis Child Fetal Neonatal Ed; 1999 Jan; 80(1):F21-5. PubMed ID: 10325806
[TBL] [Abstract][Full Text] [Related]
10. Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants.
Hirano K; Morinobu T; Kim H; Hiroi M; Ban R; Ogawa S; Ogihara H; Tamai H; Ogihara T
Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F188-93. PubMed ID: 11320046
[TBL] [Abstract][Full Text] [Related]
11. Limited protection against iron-induced lipid peroxidation by cord blood plasma.
Lindeman JH; Houdkamp E; Lentjes EG; Poorthuis BJ; Berger HM
Free Radic Res Commun; 1992; 16(5):285-94. PubMed ID: 1505787
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of chronic lung disease without preceding respiratory distress syndrome in preterm infants.
Choi CW; Kim BI; Koh YY; Choi JH; Choi JY
Pediatr Int; 2005 Feb; 47(1):72-9. PubMed ID: 15693871
[TBL] [Abstract][Full Text] [Related]
13. Ceruloplasmin and transferrin levels are altered in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome.
Krsek-Staples JA; Kew RR; Webster RO
Am Rev Respir Dis; 1992 May; 145(5):1009-15. PubMed ID: 1316727
[TBL] [Abstract][Full Text] [Related]
14. Primary plasma antioxidants in adult respiratory distress syndrome patients: changes in iron-oxidizing, iron-binding, and free radical-scavenging proteins.
Gutteridge JM; Quinlan GJ; Mumby S; Heath A; Evans TW
J Lab Clin Med; 1994 Aug; 124(2):263-73. PubMed ID: 8051491
[TBL] [Abstract][Full Text] [Related]
15. Markers of oxidative stress and antioxidant activity in plasma and erythrocytes in neonatal respiratory distress syndrome.
van Zoeren-Grobben D; Lindeman JH; Houdkamp E; Moison RM; Wijnen JT; Berger HM
Acta Paediatr; 1997 Dec; 86(12):1356-62. PubMed ID: 9475316
[TBL] [Abstract][Full Text] [Related]
16. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA
Cochrane Database Syst Rev; 2001; (2):CD001145. PubMed ID: 11405975
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary vascular permeability after cardiopulmonary bypass and its relationship to oxidative stress.
Messent M; Sinclair DG; Quinlan GJ; Mumby SE; Gutteridge JM; Evans TW
Crit Care Med; 1997 Mar; 25(3):425-9. PubMed ID: 9118657
[TBL] [Abstract][Full Text] [Related]
18. Increased ADMA levels are associated with poor pulmonary outcome in preterm neonates.
Kavurt S; Demirel N; Bas AY; Ulubas Isık D; Ozcan B; Aydemir O
J Matern Fetal Neonatal Med; 2017 Apr; 30(7):864-869. PubMed ID: 27268203
[TBL] [Abstract][Full Text] [Related]
19. Thrombin contributes to bronchoalveolar lavage fluid mitogenicity in lung disease of the premature infant.
Dik WA; Zimmermann LJ; Naber BA; Janssen DJ; van Kaam AH; Versnel MA
Pediatr Pulmonol; 2003 Jan; 35(1):34-41. PubMed ID: 12461737
[TBL] [Abstract][Full Text] [Related]
20. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial.
Durand M; Sardesai S; McEvoy C
Pediatrics; 1995 Apr; 95(4):584-90. PubMed ID: 7700763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
